Chargement en cours...
Patient-Reported Outcomes with Chimeric Antigen Receptor-T Cell Therapy: Challenges and Opportunities
Patient-reported outcomes (PROs) are an important tool to assess the impact of a new therapy on symptom burden and health-related quality of life (HRQoL). Chimeric Antigen Receptor-T (CAR-T) cell therapies have been approved for use in relapsed or refractory leukemia and lymphoma based on promising...
Enregistré dans:
| Publié dans: | Biol Blood Marrow Transplant |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6511294/ https://ncbi.nlm.nih.gov/pubmed/30500439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.11.025 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|